25% Profit Reached - Sell Proto Labs And Take Profit

| About: Proto Labs (PRLB)
This article is now exclusive for PRO subscribers.


Investors in PRLB made 25% in a very short amount of time. Congratulations to all.

I have reanalyzed the company as of today and am reevaluating my call to a SELL at $78.34. The company has reached intrinsic value.

As of now, I myself have liquidated all shares of PRLB in my portfolio.

My last article on Proto Labs Inc. (NYSE:PRLB) described the significant upside potential available to those who choose to invest in this undervalued company.

That was at $62.68. PRLB is now at $78.34 only a very short time later.

Although we have not reached my previous price target, I have reanalyzed the fundamentals of the company and will be reevaluating my call to a SELL as of now.

My updated analysis of the company reveals that at its current price of $78.34, it is now at intrinsic value.

In the spirit of full disclosure, I would like to indicate that I liquidated all shares of PRLB in my portfolio at $78.34. I congratulate those who chose to invest in PRLB at $62.68. We have made 25% ROI in a very short amount of time.

What Changed?

From a microeconomic perspective, not much.

PRLB still stands as an extraordinary company, with outstanding results. The company is obviously run by a highly competent management. However, we must be clear to distinguish between a great company and a great investment.

Having recently updated my calculations for macroeconomic risk factors and having applied these new metrics to PRLB, its current price of $78.34 is directly at intrinsic value. As such, I suggest taking profits immediately.

Disclosure: The author has no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. The author wrote this article themselves, and it expresses their own opinions. The author is not receiving compensation for it (other than from Seeking Alpha). The author has no business relationship with any company whose stock is mentioned in this article.